Liquid Biopsy

Liquid Biopsy Market Research Report: Forecast (2023-2028)

By Work Process (Sample Preparation, Library Preparation, Sequencing, Data Analysis), By Technology (PCR [RT-PCR, dPCR, Multiplex PCR, Others], NGS, FISH, Other Technologies), By Usage (RUO, Clinical) Read more

  • Healthcare
  • Dec 2022
  • 182
  • HC55013

Market Definition

Liquid Biopsy is a laboratory test done on a sample of blood, urine, or other body fluids to look for remnants of cancer cells, from tumor to slightest strain, like DNA, RNA, or other molecules released by tumorous cancer cells into the body’s fluids. It can be applied to screen early cancer, track cancer/tumor progression, assess clinical prognosis, detect recurrent tumor cells, and more. It has gained attention and is appreciated as a non-invasive technique as it is less bodily taxing than tissue biopsy due to technological advances.

Market Insights

The Global Liquid Biopsy Market is projected to grow at a CAGR of around 26% during the forecast period, i.e., 2023-28. The market is significantly driven by the rising cases and prevalence of cancer, along with the increasing awareness and preference for non-invasive treatment procedures. Furthermore, the understanding and appreciation are guided by the several benefits associated with the new liquid biopsy technique, including rapid results, low cost, early prognosis, overcoming tumor heterogeneity, low risk, and non-invasiveness.

In addition, Liquid biopsy is less mentally taxing for the patient than other methods, such as tissue biopsy, resulting in further demand in the market and is expected to significantly drive the need for the market during the forecasting years.

Report Coverage Details
Study Period Historical Data: 2018-21
Base Year: 2022
Forecast Period: 2023-28
CAGR (2023-2028) 26%
Regions Covered North America: The US, Canada, Mexico
Europe: United Kingdom, Germany, France, Spain, Italy, and Others
Asia-Pacific: China, India, Japan, South Korea, South East Asia 
South America: Brazil, and Others
Middle East & Africa: Saudi Arabia, UAE, South Africa 
Key Companies Profiled Bio-Rad Laboratories, Biocept Inc, Abcodia Ltd, Chronix Biomedical, Epic Sciences Inc, Hoffmann-La Roche AG, Cynvenio Biosystems, Inc., GUARDANT HEALTH, INC, Illumina, Inc., NeoGenomics Laboratories, Inc., Menarini Silicon Biosystems, Inc., Qiagen N.V., Thermo Fisher Scientific, Personal Genome Diagnostics, Inc., Qiagen N.V. etc.
Unit Denominations USD Million/Billion

 

Consecutively, the rising preference for market growth is boosted by cancer awareness initiatives as it can monitor tumor progression early, along with eliminating the discomfort associated with the operation. In addition, with the emergence of advanced technologies, the demand for non-invasive diagnosis and treatment is rising. As it offers a non-risk effective alternative to patients, it is expected to spur the need for liquid biopsy in the forecasting period.

Furthermore, due to the inaccessibility of direct laboratories with infrastructures to undertake the liquid biopsy tests of patients in need, the fluid biopsy industry depends on the distance collection of samples by transporting the diagnostic kits to the patient. Therefore, this rising demand for the equipment would also further accelerate the market in the future. 

Moreover, developing interest, research, and competition among significant laboratories, clinical industries, and research companies with dedicated investments from private and public organizations to fund the research for better cancer treatments. With the integration of advanced technology into the treatment process, further Market expansion could be expected.

  • In November 2020, NeoGenomics, Inc. launched a mobile phlebotomy service for biopsy tests. It ensures that the test is performed with geographical efficiency.

  1. Introduction
    1. Product Definition
    2. Research Process
    3. Market Segmentation
    4. Assumptions
  2. Preface
  3. Executive Summary
  4. Impact of COVID-19 on Global Liquid Biopsy Market
  5. Global Liquid Biopsy Market Venture Capital Ecosystem
    1. Financing By Key Investors
    2. Financing Recipient Wise Details
  6. Global Liquid Biopsy Market Outlook, 2018-2028F
    1. Market Size & Analysis
      1. Revenues
    2. Market Share & Analysis
      1. By Work Process
        1. Sample Preparation               
        2. Library Preparation
        3. Sequencing
        4. Data Analysis         
      2. By Technology
        1. PCR
          1. RT-PCR
          2. dPCR
          3. Multiplex PCR
          4. Others
        2. NGS
        3. FISH
        4. Other Technologies
      3. By Usage
        1. RUO
        2. Clinical
      4. By Sample Type
        1. Blood
        2. Urine
        3. Saliva
        4. Cerebrospinal Fluid
      5. By Products
        1. Test /Services
        2. Kits and Consumables
        3. Instruments
      6. By Circulating Biomarkers
        1. Circulating Tumor Cells
        2. Cell-free DNA
        3. Circulating Cell-Free RNA   
        4. Exosomes and Extracellular Vesicles           
        5. Others                     
      7. By Disease Type
        1. Lung Cancer
        2. Breast Cancer
        3. Prostate Cancer
        4. Colorectal Cancer
        5. Melanoma
        6. Other Cancers
        7. Non-Oncology Disorders
      8. By Clinical Application
        1. Treatment Monitoring
        2. Prognosis and Recurrence Monitoring
        3. Treatment Selection
        4. Diagnosis and Screening
      9. By Region
        1. North America
        2. South America
        3. Europe
        4. Middle East & Africa
        5. Asia-Pacific
      10. By Company
        1. Competition Characteristics
        2. Market Share & Analysis
          1. 2018
          2. 2019
          3. 2020
        3. Competitive Matrix
  7. North America Liquid Biopsy Market Outlook, 2018-2028F
    1. Market Size & Analysis
      1. Revenues
    2. Market Share & Analysis
      1. By Technology
      2. By Usage
      3. By Sample Type
      4. By Products
      5. By Circulating Biomarkers
      6. By Disease Type
      7. By Clinical Applications
      8. By Country
        1. The US Liquid Biopsy Market Outlook, 2018-2028F
          1. Market Size & Analysis
            1. Revenues
          2. Market Share & Analysis
            1. By Circulating Biomarkers
            2. By Disease Type
            3. By Clinical Applications
        2. Canada Liquid Biopsy Market Outlook, 2018-2028F
          1. Market Size & Analysis
            1. Revenues
          2. Market Share & Analysis
            1. By Circulating Biomarkers
            2. By Disease Type
            3. By Clinical Applications
        3. Mexico Liquid Biopsy Market Outlook, 2018-2028F
          1. Market Size & Analysis
            1. Revenues
          2. Market Share & Analysis
            1. By Circulating Biomarkers
            2. By Disease Type
            3. By Clinical Applications
  8. South America Liquid Biopsy Market Outlook, 2018-2028F
    1. Market Size & Analysis
      1. Revenues
    2. Market Share & Analysis
      1. By Technology
      2. By Usage
      3. By Sample Type
      4. By Products
      5. By Circulating Biomarkers
      6. By Disease Type
      7. By Clinical Applications
      8. By Country
      9.  
      10. Brazil Liquid Biopsy Market Outlook, 2018-2028F
        1. Market Size & Analysis
          1. Revenues
        2. Market Share & Analysis
          1. By Product & Service
          2. By Circulating Biomarker
          3. By Technology
          4. By Sample Type
          5. By Application
          6. By Clinical Application
  9. Europe Liquid Biopsy Market Outlook, 2018-2028F
    1. Market Size & Analysis
      1. Revenues
    2. Market Share & Analysis
      1. By Technology
      2. By Usage
      3. By Sample Type
      4. By Products
      5. By Circulating Biomarkers
      6. By Disease Type
      7. By Clinical Applications
      8. By Country
        1. Germany Liquid Biopsy Market Outlook, 2018-2028F
          1. Market Size & Analysis
            1. Revenues
          2. Market Share & Analysis
            1. By Circulating Biomarkers
            2. By Disease Type
            3. By Clinical Applications
        2. France Liquid Biopsy Market Outlook, 2018-2028F
          1. Market Size & Analysis
            1. Revenues
          2. Market Share & Analysis
            1. By Circulating Biomarkers
            2. By Disease Type
            3. By Clinical Applications
        3. The United Kingdom Liquid Biopsy Market Outlook, 2018-2028F
          1. Market Size & Analysis
            1. Revenues
          2. Market Share & Analysis
            1. By Circulating Biomarkers
            2. By Disease Type
            3. By Clinical Applications
        4. Italy Liquid Biopsy Market Outlook, 2018-2028F
          1. Market Size & Analysis
            1. Revenues
          2. Market Share & Analysis
            1. By Circulating Biomarkers
            2. By Disease Type
            3. By Clinical Applications
        5. Spain Liquid Biopsy Market Outlook, 2018-2028F
          1. Market Size & Analysis
            1. Revenues
          2. Market Share & Analysis
            1. By Circulating Biomarkers
            2. By Disease Type
            3. By Clinical Applications
  10. Middle East & Africa Liquid Biopsy Market Outlook, 2018-2028F
    1. Market Size & Analysis
      1. Revenues
    2. Market Share & Analysis
      1. By Technology
      2. By Usage
      3. By Sample Type
      4. By Products
      5. By Circulating Biomarkers
      6. By Disease Type
      7. By Clinical Applications
      8. By Country
      9. Saudi Arabia Liquid Biopsy Market Outlook, 2018-2028F
        1. Market Size & Analysis
          1. Revenues
        2. Market Share & Analysis
          1. By Circulating Biomarkers
          2. By Disease Type
          3. By Clinical Applications
    3. UAE Liquid Biopsy Market Outlook, 2018-2028F
      1. Market Size & Analysis
        1. Revenues
      2. Market Share & Analysis
        1. By Circulating Biomarkers
        2. By Disease Type
        3. By Clinical Applications
  11. South Africa Liquid Biopsy Market Outlook, 2018-2028F
    1. Market Size & Analysis
      1. Revenues
    2. Market Share & Analysis
      1. By Circulating Biomarkers
      2. By Disease Type
      3. By Clinical Applications
  12. Asia-Pacific Liquid Biopsy Market Outlook, 2018-2028F
    1. Market Size & Analysis
      1. Revenues
    2. Market Share & Analysis
      1. By Technology
      2. By Usage
      3. By Sample Type
      4. By Products
      5. By Circulating Biomarkers
      6. By Disease Type
      7. By Clinical Applications
      8. By Country
        1. China Liquid Biopsy Market Outlook, 2018-2028F
          1. Market Size & Analysis
            1. Revenues
          2. Market Share & Analysis
            1. By Circulating Biomarkers
            2. By Disease Type
            3. By Clinical Applications
        2. India Liquid Biopsy Market Outlook, 2018-2028F
          1. Market Size & Analysis
            1. Revenues
          2. Market Share & Analysis
            1. By Circulating Biomarkers
            2. By Disease Type
            3. By Clinical Applications
        3. Japan Liquid Biopsy Market Outlook, 2018-2028F
          1. Market Size & Analysis
            1. Revenues
          2. Market Share & Analysis
            1. By Circulating Biomarkers
            2. By Disease Type
            3. By Clinical Applications
        4. South Korea Liquid Biopsy Market Outlook, 2018-2028F
          1. Market Size & Analysis
            1. Revenues
          2. Market Share & Analysis
            1. By Circulating Biomarkers
            2. By Disease Type
            3. By Clinical Applications
        5. South East Asia Liquid Biopsy Market Outlook, 2018-2028F
          1. Market Size & Analysis
            1. Revenues
          2. Market Share & Analysis
            1. By Circulating Biomarkers
            2. By Disease Type
            3. By Clinical Applications
  13. Global Liquid Biopsy Market List of Biopsies Approved by The Governments
  14. Global Liquid Biopsy Market Policies, Regulations, Product Standards
    1. The United States
    2. European Union
  15.  Global Liquid Biopsy Market Intellectual Property Rights Insights
    1. Patent Portfolio of Leading Players
    2. Patent Filings, Registrations and Expiration
  16. Global Liquid Biopsy Market Trends & Insights
  17. Global Liquid Biopsy Market Dynamics
    1. Growth Drivers
    2. Challenges
    3. Impact Analysis
  18. Global Liquid Biopsy Market Hotspot & Opportunities
  19. Competition Outlook
    1. Competition Matrix
      1. Product/ Solution Portfolio
      2. Target Markets
      3. Target End Users
      4. Research & Development
      5. Strategic Alliances
      6. Strategic Initiatives
    2. Competitor Capability Matrix
      1. By Technology
      2. By Sample Type
      3. By Biomarker
      4. By Application
    3. Company Profiles of Top Companies (Business Description, Product Segments, Business Segments, Financials, Strategic Alliances/ Partnerships, Future Plans)
      1. Bio-Rad Laboratories
      2. Biocept Inc
      3. Abcodia Ltd
      4. Chronix Biomedical
      5. Epic Sciences Inc
      6. Hoffmann-La Roche AG  
      7. Cynvenio Biosystems, Inc.          
      8. GUARDANT HEALTH, INC  
      9. Illumina, Inc.
      10. NeoGenomics Laboratories, Inc.
      11. Menarini Silicon Biosystems, Inc.
      12. Qiagen N.V.
      13. Thermo Fisher Scientific
      14. Personal Genome Diagnostics, Inc.
      15.  Qiagen N.V.
  20. Disclaimer
Liquid Biopsy Market Segmentation
*This field is required